Clinical trial
Sitosterolemia Extension Study (0653-003)(COMPLETED)
NCT00092807 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092807 |
|---|---|
| Title | Sitosterolemia Extension Study (0653-003)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia - 1 Year Open-Label Extension |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lipid Metabolism, Inborn Errors, Heart Disease |
| Intervention type | Drug |
| Interventions | MK0653, ezetimibe, Comparator: placebo |
| Enrollment | 37 |
| Start date | Feb 12, 2001 |
| Primary completion | Sep 18, 2001 |
| Completion | Nov 30, 2004 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: